“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its initial product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor. Mineralys is headquartered in Radnor, Pennsylvania. For more information, please visit https://mineralystx.com. Follow Mineralys on LinkedIn, Twitter and Bluesky”
Mineralys is a fully remote company.
Director, Commercial Operations-East
This role will be responsible for commercial sales operations to support the development & launch of lorundrostat in hypertension.
- Role will act as the primary liaison of commercial operations to field colleagues
- Guide field CRM implementation and maintenance with CRM implementation vendor based on input with cross functional field colleagues (Sales, Medical Affairs, Market Access)
- Review incentive compensation & Rx allocation challenges
- Manage field alignment including field roster, zip to terr, HCO/HCP targeting and alignment and DCRs with input from field colleagues and analytics vendor.
- Roster management upkeep.
- Coordinate/manage sample operations and logistics with sampling vendor and field colleagues.
- Work with fleet vendor to coordinate fleet operations and logistics along with field leadership.
- Help train field colleagues on subnational data sources, reporting tools, CRM, sampling & fleet logistics
- Facilitating credentialing & state licensing of field colleagues
- In addition to supporting field colleagues:
- 1 director will be the point/lead for CRM implementation, training and administration
- 1 director will be the point/lead for sampling logistics and fleet vendor management
Skills and Attributes
- Excellent interpersonal & communication skills required to work with and help train numerous cross functional colleagues
- Powerpoint presentation skills
- Reporting Tools
- Veeva suite of commercial platforms (i.e. Veeva CRM, OpenData/Network).
- Experience with incentive compensation reporting and challenges
Education and Experience
- 8+ Years in Biotech / Pharmaceutical Industry
- 3+ years experience in commercial operations or field training required
- 3+ years field experience as a representative / 1L manager / medical science liaison is required
- Experience managing multiple vendors (e.g CRM design, IC, sampling, fleet) and working relationships with relevant vendors is preferred
- Experience working with many “internal customers” such as field teams is required
- Demonstrated success in optimizing field force effectiveness by leveraging performance metrics and implementing deployment, alignment and targeting strategies.
Travel
- This position requires up to 15% travel. Frequently travel is outside the local area and overnight.
US Salary Range: $160,000 - $185,000
#LI-Remote
Skills Required
- 8+ years in Biotech/Pharmaceutical industry
- 3+ years experience in commercial operations or field training
- 3+ years field experience as a sales representative, 1L manager, or medical science liaison
- Experience managing multiple vendors (CRM design, incentive comp, sampling, fleet)
- Experience working with many internal customers such as field teams
- Demonstrated success optimizing field force effectiveness using performance metrics and deployment/targeting strategies
- Excellent interpersonal and communication skills
- PowerPoint presentation skills
- Experience with reporting tools
- Experience with Veeva suite of commercial platforms (Veeva CRM, OpenData/Network)
- Experience with incentive compensation reporting and challenges
What We Do
Mineralys Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing lorundrostat, a proprietary oral aldosterone synthase inhibitor, to treat uncontrolled and resistant hypertension and related cardiorenal disorders (including CKD and OSA). The company focuses on targeted therapies for diseases driven by dysregulated aldosterone and is advancing late-stage clinical programs and regulatory filings to bring this treatment to patients.
